<DOC>
	<DOCNO>NCT01815853</DOCNO>
	<brief_summary>Background : It show patitents gastric cancer could benefit peri-operative chemoradiotherapy , whether pre-operative chemoradiotherapy improve patitents ' outcome still unclear . Patients method : In study , patient histologically confirm gastric cancer whose pre-operative staging cT4 N , MO , age 18 70 year Eastern Cooperative Oncology Group performance status â‰¤2 adequate organ function , randomize 1:1 receive pre-operative chemoradiotherapy DT45Gy/25f plus two cycle XELOX ( Xeloda 1000mg/m2 , BID , DI-D14 ; Oxaliplatin 130mg/m2 day 1 ; ,21-days per cycle ) chemotherapy alone follow surgical resection adjuvant chemotherapy XELOX dose 4 cycle . The primary end point overall survival ( OS ) , secondary end point disease free survival ( DFS ) safety . Final study analysis conduct end 5th year last patient 's enrollment .</brief_summary>
	<brief_title>Pre-operative Chemoradiotherapy Chemotherapy Following Surgery Adjuvent Chemotherapy Patients With Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>inform consensus patient able receive oral administration 18 70 year old proven primary adenocarcinoma gastric cancer preoperative stag cT4 , N , MO , without chemotherapy and/or radiation disease normal function organ include heart , liver , kidney Eastern Cooperative Oncology Group performance status:0~2 history malignancy allergic reaction xeloda oxaliplatin enrol clinical trial abnormal GI tract function dysfunction organ female pregnancy lactation , refuse receive Contraception measure chemotherapy situation judge adaptive study investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>pre-operative ,</keyword>
	<keyword>chemoradiotherapy ,</keyword>
	<keyword>chemotherapy ,</keyword>
	<keyword>treatment</keyword>
	<keyword>outcome</keyword>
</DOC>